Answer:
<em>(e) top-down processing</em>
Explanation:
Since the brain is basically focused on the sensory systems higher.
Higher-level stages of cognition such as reasoning, are therefore known to be at the top of the process of feeling and perception.
But at the other hand, low-level brain structures, like those participating in sight, touch, or hearing sensory systems, are known to be at the bottom.
Top-down processing refers to how our brains use information that one or more of the sensory systems have already put into the brain.
It is a cognitive process that begins with our emotions, flowing down to functions at lower levels, such as the senses.
Answer:
b. only one promise is involved in a unilateral contract.
Explanation:
An unilateral contract is a contract where the person or the offeror making the contract promises for the execution of the task by the other party. It can be accepted only be a performance.
In unilateral contract, there is only one promisor and no promisee is required whereas is bilateral contract includes both the promisor and the promisee.
Thus the correct answer is
b. only one promise is involved in a unilateral contract.
Answer:c. Learning .
Explanation:
Learning as related to psychology explains how environment and experience affects the behavioral pattern of a person or animal.
None, drive vehicles that carry 14 passengers or less or people who transport goods at work
Answer:
An institutional review board (IRB), also known as an independent ethics committee (IEC), ethical review board (ERB), or research ethics board (REB), is a type of committee that applies research ethics by reviewing the methods proposed for research to ensure that they are ethical.
Explanation:
- Conducting initial and continuing review of research;
- Reporting findings and actions to the investigator and the institution;
- Determining which projects require review more often than annually;
- Determining which projects need verification from sources other than the investigator that no material changes have occurred since previous IRB review;
- Ensuring prompt reporting to the IRB of proposed changes in a research activity, and ensuring that changes in approved research, during the period for which IRB approval has already been given, may not be initiated without IRB review and approval except where necessary to eliminate apparent immediate hazards to the human subjects;
- Ensuring prompt reporting to the IRB, appropriate institutional officials, any department or agency head and OHRP for research conducted or supported by HHS, and the FDA for FDA-regulated research of:
- Any unanticipated problems involving risks to human subjects or others;
- Any instance of serious or continuing noncompliance with the applicable HHS and FDA regulations or the requirements or determinations of the IRB; Any suspension or termination of IRB approval.
HHS and FDA regulations do not provide additional detail on the content of IRB written procedures, which gives IRBs the flexibility to establish procedures best suited to their own operations.
